XYWAV: payments to doctors
Payments that named XYWAV as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $13.7M
- Providers
- 11,408
- Transactions
- 78,543
- Average per transaction
- $175
The per-transaction average — $175 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,408 providers the average total is $1,204, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| JAZZ Pharmaceuticals Inc. | $12,595,803 | 91.7% |
| Jazz Pharmaceuticals Inc. | $1,141,618 | 8.3% |